Davis J. E. 4

What Happened
Davis J. E., CEO, President and Director of Quest Diagnostics (DGX), sold 10,000 shares on June 1, 2026. The shares were disposed at $194.14 per share for a total value of $1,941,400. This was an open-market sale (transaction code S), which is commonly a routine disposition rather than a direct signal of company outlook.

Key Details

• Transaction date and price: 2026-06-01 at $194.14 per share.
• Shares sold / proceeds: 10,000 shares for $1,941,400.
• Shares owned after transaction: Not disclosed in this Form 4 filing.
• Footnote: Sale effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person (prearranged trading plan).
• Filing: Form 4 filed 2026-06-02 (one day after the trade), within the typical two-business-day reporting window (timely).

Context
Rule 10b5-1 plans allow insiders to sell shares according to a preset schedule and can reduce the inference that a sale reflects the insider’s current view of the company. As with most sales, this transaction is factual information for investors but does not by itself indicate management sentiment or company performance.